EVERSOURCE ENERGY (ES) Stock News

Rosen Law Firm is encouraging investors who purchased securities of Lincoln Educational Services (LINC), AST SpaceMobile (ASTS), and Beta Bionics (BBNX) during specified class periods to join securities class action lawsuits. The firm reminds investors of important lead plaintiff deadlines and notes that class actions have already been filed alleging false and misleading statements by defendants.

A securities class action lawsuit has been filed against AST SpaceMobile, Inc. for allegedly making false and misleading statements regarding its capital requirements, liquidity position, competitive standing in the satellite D2C market, and user adoption rates. Investors who purchased securities between March 4, 2025 and July 15, 2026 may be eligible for compensation. The lead plaintiff deadline is November 13, 2026.

Rosen Law Firm is reminding investors in Baidu, Inc., AST SpaceMobile, Inc., and Beta Bionics, Inc. about upcoming deadlines to join securities class action lawsuits. The lawsuits allege that these companies made false or misleading statements regarding their business operations and financial prospects. Investors who purchased securities during specified class periods may be eligible for compensation.

Rosen Law Firm is reminding investors in Tigo Energy, AST SpaceMobile, and Beta Bionics of upcoming deadlines to join securities class action lawsuits. The firm alleges that Tigo Energy made false revenue projections based on an EG4 partnership that would not materialize until Q4 2026 at the earliest, resulting in materially misleading statements about the company's business and prospects.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Dun & Bradstreet Holdings, alleging false and misleading statements regarding a merger with Clearlake Capital Group, including omissions about executive interests and financial advisor conflicts. Additional cases involve Duolingo, Inc. and XTI Aerospace, Inc. The lead plaintiff deadline for the DNB case is November 10, 2026.

Rosen Law Firm is urging Duolingo investors who purchased stock between May 2, 2025 and February 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Duolingo made false statements about user growth by concealing that increased monetization efforts, ad volume, and lower-quality AI-generated content were negatively impacting daily active users and product quality. The lead plaintiff deadline is December 7, 2026.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that the company made materially false and misleading statements regarding its Revita product's effectiveness and clinical trial integrity. Investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026 have until October 20, 2026 to apply as lead plaintiff.

A securities class action lawsuit has been filed against Better Home & Finance Holding Company (BETR) for allegedly making false and misleading statements about its conversion funnel and $1 billion monthly funded volume target. Investors who purchased BETR securities between March 13, 2026 and May 7, 2026 are encouraged to join the class action before the November 20, 2026 lead plaintiff deadline.

Rosen Law Firm is urging FuelCell Energy (FCEL) investors who purchased securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false statements about its business, concealing inadequate manufacturing capacity, slower production rates, higher costs, and likely CEPA-related charges that materially misled investors. The lead plaintiff deadline is November 10, 2026.

Rosen Law Firm has filed a class action lawsuit against Triller Group Inc. (NASDAQ: ILLR) on behalf of investors who purchased securities between October 16, 2024 and December 29, 2025. The lawsuit alleges that Triller made materially false and misleading statements regarding its control of BKFC, financial reporting compliance, NASDAQ listing requirements, and disclosure controls. Investors who wish to serve as lead plaintiff must file by December 14, 2026.

A shareholder class action lawsuit has been filed against D-Wave Quantum Inc. (NASDAQ: QBTS), alleging that the company made false and misleading statements and overstated its business and financial prospects. Investors who purchased shares between February 26, 2026 and August 25, 2026 and experienced losses are encouraged to contact the law firm. The deadline to be appointed lead plaintiff is December 14, 2026.

Rosen Law Firm has filed securities class action lawsuits against Millrose Properties, Hims & Hers Health, and Doximity for alleged disclosure failures and misleading statements to investors. Millrose Properties is accused of misrepresenting its business objectives and leasing properties at a loss. Investors have until December 8, 2026 to move the court to serve as lead plaintiff.

Value Line, Inc. (NASDAQ: VALU) announced a quarterly cash dividend of $0.35 per common share, payable on November 10, 2026, to stockholders of record on October 26, 2026. The company has 9,382,098 shares of common stock outstanding as of October 16, 2026.

David Solomon, CEO of Goldman Sachs, has been named the new chair of The Business Council, succeeding Brian Cornell of Target Corporation. Solomon will lead the organization during a pivotal period marked by AI advancement and complex global economic challenges. The Business Council, established in 1933, serves as a forum for world-leading CEOs to collaborate on business solutions.

Tango Therapeutics announced it will present updated Phase 1/2 study data on vopimetostat combined with daraxonrasib or zoldonrasib for treating MTAP-deleted RAS-mutant metastatic pancreatic and lung cancers at the ESMO Congress 2026 in Madrid. The company will also host a PDAC-focused investor webcast on October 23, 2026.

Rosen Law Firm has filed a securities class action lawsuit against Netcapital Inc. on behalf of investors who purchased securities between December 15, 2021 and September 3, 2026. The lawsuit alleges that Netcapital made false statements and failed to disclose improper revenue recognition from sham consulting agreements, backdated and forged contracts, undisclosed related-party transactions, and false Sarbanes-Oxley certifications. Investors must move the court by December 7, 2026 to serve as lead plaintiff.

Rosen Law Firm is urging investors who purchased Lincoln Educational Services Corporation (LINC) securities between May 11, 2026 and August 9, 2026 to join a class action lawsuit before the November 10, 2026 deadline. The lawsuit alleges that defendants made false statements about the company's admissions process and student conversion rates, claiming the company experienced a significant drop in student starts relative to enrollment, making positive statements about the business materially misleading.

Rosen Law Firm is notifying Beta Bionics, Inc. investors of a November 3, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made false statements about its iLet Bionic Pancreas insulin pump, which the FDA found to be malfunctioning and causing dangerously high insulin dosing. The company allegedly failed to implement meaningful corrective actions despite thousands of complaints and hundreds of life-threatening events.

Vallourec, a world leader in premium seamless tubular solutions, will showcase its VAM® portfolio and expanded CLEANWELL® dope-free solution at ADIPEC 2026 in Abu Dhabi (November 2-5, 2026). The company will present VAM® 21, VAM® HTTC connections, VAM® SPRINT-TC for unconventional applications, and Delphy, its hydrogen storage solution, alongside Vallourec® Services offerings.

Robbins Geller announces a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertising platforms and charging for prescriptions immediately after intake forms despite claiming personalized consultations. The FTC filed a lawsuit on July 29, 2026, leading to a 15% decline in Hims & Hers stock. Investors with substantial losses can seek lead plaintiff status before November 2, 2026.

Rosen Law Firm has filed a class action lawsuit against Duolingo, Inc. on behalf of investors who purchased Class A common stock between May 2, 2025 and February 26, 2026. The lawsuit alleges that Duolingo made materially false statements regarding Daily Active User growth, failed to disclose that increased user friction from ads and subscription upsells was negatively impacting DAU growth, and that low-quality AI-generated content was degrading the product experience and user retention. The lead plaintiff deadline is December 7, 2026.

Rosen Law Firm is notifying investors of Qfin Holdings who purchased securities between March 18, 2026 and August 25, 2026 of an important November 30, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Qfin defendants made false and misleading statements regarding the resiliency of the company's business and downplayed the negative impact of regulatory headwinds on financial results.

Rosen Law Firm is urging AST SpaceMobile investors who purchased securities between March 4, 2025 and July 15, 2026 to join a securities class action lawsuit before the November 13, 2026 lead plaintiff deadline. The lawsuit alleges that AST SpaceMobile made false statements regarding its capital requirements, liquidity position, competitive standing in the satellite D2C market, and user adoption rates in the U.S. and Japan.

Rosen Law Firm has filed securities class action lawsuits against FuelCell Energy, Hyliion Holdings, and Tigo Energy, alleging that defendants made false and misleading statements regarding their business operations and financial prospects. Investors who purchased securities during specified class periods are encouraged to secure counsel before upcoming deadlines, with the FuelCell case having a November 10, 2026 lead plaintiff deadline.

Rosen Law Firm has filed a securities class action lawsuit against The Ensign Group, Inc. on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare billing, falsification of nursing assistant hours, and illegal licensing schemes. Investors who wish to serve as lead plaintiff must file by December 7, 2026.

Rosen Law Firm announces a securities class action lawsuit against DICK'S Sporting Goods, alleging the company made materially false and misleading statements regarding its Foot Locker acquisition cleanup efforts and exposure to excess inventory and promotional pressures in the athletic footwear industry. Investors who purchased DKS stock between September 8, 2025 and August 24, 2026 may be eligible for compensation. The lead plaintiff deadline is November 3, 2026.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Coastal Financial Corporation on behalf of investors who purchased securities between October 28, 2024 and July 29, 2026. The lawsuit alleges that Coastal failed to disclose material deterioration in a $500 million CCBX partner loan portfolio and inadequate risk management practices. On July 30, 2026, Coastal announced a $42.1 million net loss driven by a $68.8 million credit expense, causing the stock to plunge 43.5% from $70.66 to $39.91 per share.

A securities fraud class action lawsuit has been filed against Alphabet Inc. on behalf of investors who purchased securities between May 19, 2026 and July 16, 2026. The lawsuit alleges that Alphabet failed to disclose that its Gemini 3.5 Pro AI model was delivering disappointing training results and would face significant launch delays. Following Bloomberg's July 16 report confirming the delays, Alphabet shares declined 4.4%. Google subsequently announced it would release Gemini 4 Argon instead and no longer plans to release Gemini 3.5 Pro.

Rosen Law Firm is urging investors who purchased Ardelyx common stock between January 13, 2025 and August 6, 2026 to join a securities class action lawsuit. The lawsuit alleges that Ardelyx provided misleading statements about its commercial performance and concealed material facts regarding reimbursement barriers and access issues for its drugs XPHOZAH and IBSRELA, resulting in investor damages.

Western Midstream (WES) closed at $44.82, down 1.1% in the latest session. The oil and gas transportation company is projected to report quarterly EPS of $0.89 (up 2.3% YoY) and revenue of $1.2 billion (up 25.52% YoY). WES carries a Zacks Rank #2 (Buy) rating with a Forward P/E of 12.37, trading at a slight premium to its industry average.